Home DailyMed 74ffbc72-59cd-41e8-8146-722f5cf8a14b National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:03:54 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021087-001 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 N021087-002 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 N021087-003 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021087-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021087-002 TAMIFLU EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021087-003 TAMIFLU EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021087-002 TAMIFLU EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021087-003 TAMIFLU EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2007-07-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL RLD 2007-07-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL RLD 2007-07-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL RLD 2007-07-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL RLD 2007-07-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021087-002 TAMIFLU EQ 45MG BASE CAPSULE / ORAL AB RLD 2007-07-02 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021087-003 TAMIFLU EQ 30MG BASE CAPSULE / ORAL AB RLD 2007-07-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021087-001 TAMIFLU EQ 75MG BASE CAPSULE / ORAL AB RLD, RS 1999-10-27 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 119 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 42 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.